The Prognostic Role of Procalcitonin in Critically Ill Patients Admitted in a Medical Stepdown Unit: A Retrospective Cohort Study
暂无分享,去创建一个
V. Zaccone | L. Falsetti | A. Marchetti | A. Salvi | C. Nitti | Mattia Sampaolesi | Francesca Riccomi | T. Gentili | Maria‐Novella Piersantelli | Alessia Raponi | M. Sampaolesi
[1] Gang Liu,et al. Clinical analysis of 215 consecutive cases with fever of unknown origin , 2018, Medicine.
[2] T. Osborn,et al. Sepsis in the older person: The ravages of time and bacteria , 2018, Emergency medicine Australasia : EMA.
[3] M. Delgado-Rodríguez,et al. Systematic review and meta-analysis. , 2017, Medicina intensiva.
[4] Michel Wolff,et al. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections. , 2017, The Cochrane database of systematic reviews.
[5] T. Walsh,et al. Early troponin I in critical illness and its association with hospital mortality: a cohort study , 2017, Critical Care.
[6] Ashitha L. Vijayan,et al. Procalcitonin: a promising diagnostic marker for sepsis and antibiotic therapy , 2017, Journal of Intensive Care.
[7] Christopher W Seymour,et al. Developing a New Definition and Assessing New Clinical Criteria for Septic Shock: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). , 2016, JAMA.
[8] Adil Rafiq Rather,et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) , 2015 .
[9] L. Su,et al. Prognostic Value of Procalcitonin in Adult Patients with Sepsis: A Systematic Review and Meta-Analysis , 2015, PloS one.
[10] H. Wunsch,et al. The role of stepdown beds in hospital care. , 2014, American journal of respiratory and critical care medicine.
[11] Fiona Lecky,et al. The Glasgow Coma Scale at 40 years: standing the test of time , 2014, The Lancet Neurology.
[12] T. van der Poll,et al. Severe sepsis and septic shock. , 2013, The New England journal of medicine.
[13] P. Schlattmann,et al. Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis. , 2013, The Lancet. Infectious diseases.
[14] J. Dekker,et al. Promising new assays and technologies for the diagnosis and management of infectious diseases. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[15] J. Jensen,et al. Procalcitonin increase in early identification of critically ill patients at high risk of mortality* , 2006, Critical care medicine.
[16] Stephen Gatesy,et al. Standing the test of time , 2003, Nature.
[17] M. Meisner,et al. Early increase of procalcitonin after cardiovascular surgery in patients with postoperative complications , 2002, Intensive Care Medicine.
[18] C. Subbe,et al. Validation of a modified Early Warning Score in medical admissions. , 2001, QJM : monthly journal of the Association of Physicians.
[19] G. Ricevuti,et al. Plasma Levels of Procalcitonin and Interleukin-6 in Acute Myocardial Infarction , 2001, Inflammation.
[20] S. Lemeshow,et al. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study , 1993 .
[21] D M Linton,et al. Severity of disease classification system. , 1991, Critical care medicine.
[22] W. Knaus,et al. APACHE II: a severity of disease classification system. , 1985 .
[23] J. Parrillo,et al. Cardiogenic Shock , 1971, Journal of the American Heart Association.
[24] M. Al-Haddad,et al. Recognizing the critically ill patient , 2013 .
[25] J. Vincent,et al. Circulatory shock. , 2013, The New England journal of medicine.
[26] S. Lemeshow,et al. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. , 1993, JAMA.